I examined the letter; here&#x27;s what it says: Theranos&#x27;s lab isn&#x27;t CLIA-compliant in a way that potentinally puts patients at serious risk.  DHHS is giving them 10 days to remedy some serious noncompliance issues (without reading the CMS-2567 form, I can&#x27;t see for certain what magnitude they are), but this is very serious.  If Theranos doesn&#x27;t reply satisfactorily, DHHS will fine them daily and possibly revoke their CLIA certs as well as their ability to take Medicare money.<p>I think most people had already concluded that the company, if not outright fraudulent, was being very careful to hide a number of negative facts about their product&#x27;s deficiencies.  At this point nearly every scientist I know thinks their tech doesn&#x27;t really work as well as they claimed, so it seems unlikely the company should have the valuation it does.